Latest

  • Bioethics

    Treatment of Subject Injury: Fair is Fair

    By Suzanne M. Rivera, Ph.D. Of all the protections provided in the Common Rule to safeguard the rights and welfare of research participants, there’s one glaring omission: treatment of study-related injuries. Our current regulatory apparatus…

    Treatment of Subject Injury: Fair is Fair

  • Abortion

    Conscientious Actions and Refusals

    Great new Perspectives piece by Lisa Harris out in NEJM on the need to recognize that conscience can compel action, not only refusals to provide certain types of care (including abortion).  Elizabeth Sepper makes a similar…

    Conscientious Actions and Refusals

  • Bioethics

    California Surrogacy Bill Reacts to Lawyer Bad Acts

    [posted on behalf of Judy Daar] Mishaps in assisted reproductive technologies (ART) breed public outcries and legislative hand-wringing.  It is no wonder a 2011 San Diego-based ART debacle dubbed “an international baby-selling ring” caught the attention…

    California Surrogacy Bill Reacts to Lawyer Bad Acts

  • Abortion

    Is the Self Defense Exception Consistent with the Belief that a Fetus is a Person?

    In Glenn Cohen’s first post on this blog, he questioned whether Mitt Romney’s position on abortion was coherent with respect to the rape and incest exception, but did not question the self-defense exception itself.  He…

    Is the Self Defense Exception Consistent with the Belief that a Fetus is a Person?

  • FDA

    Is FDA’s 2013 Budget At Risk?

    By Patrick O’Leary Back in February, President Obama’s FY 2013 budget authorized $4.5 billion for the Food and Drug Administration (FDA), about $2 billion of which was to come from user fees, the fees paid…

    Is FDA’s 2013 Budget At Risk?

  • Bioethics

    Sunder on Patents and Access to Drugs

    By Frank Pasquale Last week, the blog Concurring Opinions featured a symposium on Madhavi Sunder’s new book, From Goods to a Good Life: Intellectual Property and Global Justice. A chapter relevant to health law scholars…

    Sunder on Patents and Access to Drugs

  • Alvin Roth

    New Books on Markets for Organs

    Over at Market Design, Al Roth has drawn our attention to two new books addressing organ markets: A Market in Organs  (in Kidney Transplantation: Challenging the Future) Miran Epstein  and Matching Organs with Donors: Legality and…

    New Books on Markets for Organs

  • Publications

    Yale’s Friday Newsletter – 09/14/12

    Here’s this week’s newsletter from the Yale Interdisciplinary Center for Bioethics, with the latest bioethics news, scholarship, opinion, and other announcements.  Take a look!

    Yale’s Friday Newsletter – 09/14/12

  • Arthur Caplan

    Greenpeace Out to Sea on GM Rice Issue

    [posted on behalf of Art Caplan] Greenpeace, perhaps best known for its battles at sea to protect whales and the oceans, has gotten itself involved in a huge controversy over genetically modified food. The group is…

    Greenpeace Out to Sea on GM Rice Issue

  • Introductions

    Introducing Judith Daar

    We’re excited to welcome Judith Daar, the Associate Dean for Academic Affairs and Professor of Law at Whittier Law School, as an occasional contributor to the blog.

    Introducing Judith Daar